Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3′- triiodothyronine therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 11, 2005, Pages 6296-6299

  Appelhof, Bente C ^a   Peeters, Robin P ^b   Wiersinga, Wilmar M ^a   Visser, Theo J ^b   Wekking, Ellie M ^a   Huyser, Jochanan ^a   Schene, Aart H ^a   Tijssen, Jan G P ^a   Hoogendijk, Witte J G ^c   Fliers, Eric ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEIODINASE 2; HYDROLASE; LIOTHYRONINE; THYROXINE; THYROXINE DEIODINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COGNITION; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; WELLBEING;

ADULT; FEMALE; GENOTYPE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; IODIDE PEROXIDASE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; THYROXINE; TRIIODOTHYRONINE;

EID: 27744525730     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0451     Document Type: Article

References (14)

1. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM 2002 Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 57:577-585
2. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange Jr AJ 1999 Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 340:424-429
3. Clyde PW, Harari AE, Getka EJ, Shakir KM 2003 Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA 290:2952-2958
4. 4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88:4551-4555
5. Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sanger E, Engel G, Hamm AO, Nauck M, Meng W 2004 Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf) 60:750-757
6. Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, Dhaliwal SS, Chew GT, Bhagat MC, Cussons AJ 2003 Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 88:4543-4550
7. Escobar-Morreale HF, Botella-Carretero JI, Gomes-Bueno M, Galan JM, Barrios V, Sancho J 2005 Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 142:412-424
8. Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, Endert E, van Weert HC, Wiersinga WM 2005 Combined therapy with levothyroxine and liothyronine in two ratios compared with levothyroxine monotherapy in primary hypothyroidism: a double blind randomized controlled clinical trial. J Clin Endocrinol Metab 90:2666-2674
9. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG, Visser TJ 2003 Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 88:2880-2888
10. Peeters RP, van den Beld AW, Attalki H, Toor H, de Rijke YB, Kuiper GG, Lamberts SW, Janssen JA, Uitterlinden AG, Visser TJ 2005 A new polymorphism in the type 2 deiodinase (D2) gene is associated with circulating thyroid hormone parameters. Am J Physiol Endocrinol Metab 289:E75-E81
11. Cooper DS 2001 Clinical practice. Subclinical hypothyroidism. N Engl J Med 345:260-265
12. Toft AD 2001 Clinical practice. Subclinical hyperthyroidism. N Engl J Med 345:512-516
13. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TI, Poehlman ET, Shuldiner AR, Celi FS 2002 Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the β3-adrenergic receptor. Diabetes 51:880-883
14. Canani LH, Capp C, Dora JM, Meyer EL, Wagner MS, Harney JW, Larsen PR, Gross JL, Bianco AC, Maia AL 2005 The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 90:3472-3478